109 related articles for article (PubMed ID: 2874084)
1. Prognostic value of a malignancy grading system in treatment of recurrent cervical carcinoma.
Sorbe B; Lannes P
Int J Gynaecol Obstet; 1986 Apr; 24(2):151-5. PubMed ID: 2874084
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
3. [The immediate results of the combined chemotherapy of disseminated forms and recurrences of cervix uteri cancer with vincristine, platidiam and adriamycin].
Zabunov AV; Dudareva LA
Vopr Onkol; 1991; 37(11-12):1090-4. PubMed ID: 1669203
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, Adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinoma.
Lele SB; Piver MS; Barlow JJ
Gynecol Oncol; 1983 Aug; 16(1):15-8. PubMed ID: 6688405
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
6. Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix.
Levi JA; Wheeler HR; Friedlander M; Tattersall MH; Kefford R; Dalley D
Gynecol Oncol; 1992 Jun; 45(3):329-33. PubMed ID: 1377155
[TBL] [Abstract][Full Text] [Related]
7. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-adriamycin-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent cervical carcinoma.
Sorbe B; Frankendal B
Obstet Gynecol; 1984 Feb; 63(2):167-70. PubMed ID: 6198610
[TBL] [Abstract][Full Text] [Related]
9. Cis-platinum-adriamycin-cyclophosphamide in the treatment of advanced-recurrent cervical cancer.
Villalon AH; Lu-Lim JY; Esteba DV; Manalo A; Sotto L; Jimenez MV; Agustin BM
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):660-4. PubMed ID: 3841763
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix.
Symonds RP; Burnett RA; Habeshaw T; Kaye SB; Snee MP; Watson ER
Br J Cancer; 1989 Mar; 59(3):473-5. PubMed ID: 2467687
[TBL] [Abstract][Full Text] [Related]
11. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Shimizu Y
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
[TBL] [Abstract][Full Text] [Related]
13. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
[TBL] [Abstract][Full Text] [Related]
14. A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma.
Li WP; Liu H; Chen L; Yao YQ; Zhao EF
Asian Pac J Cancer Prev; 2015; 16(11):4629-31. PubMed ID: 26107215
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin, vincristine, and methotrexate with citrovorum factor rescue in the treatment of advanced squamous cell carcinoma of the cervix.
Hannigan EV; Dillard EA; Dinh TV
Gynecol Oncol; 1984 Sep; 19(1):57-9. PubMed ID: 6205946
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for advanced or recurrent carcinoma of the cervix.
Bloss JD
Curr Oncol Rep; 2001 Jan; 3(1):33-40. PubMed ID: 11123867
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic grading and prognosis of uterine cervical carcinoma.
Bichel P; Jakobsen A
Am J Clin Oncol; 1985 Jun; 8(3):247-54. PubMed ID: 4050744
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer].
Mizuno K; Kidokoro K; Miyazaki K; Yoshida K; Nakagawa A; Mizuno M; Suzuki S; Kuno N; Furuhashi M; Ishizuka T; Ishikawa K
Gan To Kagaku Ryoho; 2005 Jun; 32(6):815-9. PubMed ID: 15984522
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
